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Abstract
Background: Patients with brief depressive episodes and concurrent rapidly fluctuating
psychiatric symptoms do not fit current diagnostic criteria and they can be difficult to diagnose and
treat in an acute psychiatric setting. We wanted to study whether these patients had signs of more
epileptic or organic brain dysfunction than patients with depression without additional
symptomatology.
Methods: Sixteen acutely admitted patients diagnosed with a brief depressive episode as well as
another concurrent psychiatric diagnosis were included. Sixteen patients with major depression
served as controls. Three electroencephalographic studies (EEG) were visually interpreted and the
background activity was also analysed with quantitative electroencephalography (QEEG).
Results: The group with brief depression and concurrent symptoms had multiple abnormal
features in their standard EEG compared to patients with major depression, but they did not show
significantly more epileptiform activity. They also had significantly higher temporal QEEG delta
amplitude and interhemispheric temporal delta asymmetry.
Conclusion: Organic brain dysfunction may be involved in the pathogenesis of patients with brief
depressive episodes mixed with rapidly fluctuating psychiatric symptoms. This subgroup of
depressed patients should be investigated further in order to clarify the pathophysiology and to
establish the optimal evaluation scheme and treatment in an acute psychiatric setting.
Background
The psychiatric acute and intensive care units serve a
broad spectrum of acutely admitted patients. A limited
number of patients presents with brief depressive periods
intervened with rapidly alternating psychiatric symptoms
more typical of other psychiatric diagnoses than depres-
sion. These patients fail to meet current diagnostic criteria
for affective disorders and the optimal treatment is not
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this condition Acute Unstable Depressive Syndrome
(AUDS) and the specific criteria are defined in the meth-
ods section.
It is important to study subsyndromes of depression with
EEG and other imaging techniques as possible differential
diagnoses in such patients may be psychiatric disorders
associated with epilepsy. Psychiatric disorders associated
with epilepsy seem to be clinically distinct [1], and affec-
tive disorders and depression, often with atypical clinical
presentations failing to meet current DSM-IV criteria, are
the most frequent [2,3]. Studies of epilepsy or other
organic brain dysfunctions in psychiatric acute depart-
ments are sparse [4]. However, it is important to identify
patients with atypical depressive syndromes because treat-
ment with traditional antidepressants might induce cycle
acceleration in some patients with affective disorders
[5,6]. Recognition of organic brain syndromes, like epi-
lepsy, is important in acute wards in order to identify
patients who may benefit from treatment with antiepilep-
tic drugs [7].
Electroencephalography (EEG) is the best method to diag-
nose epileptic seizures and syndromes. EEG may also be
useful in treatment selection [8,9] and classification
[10,11] of mood disorders. Subgroups with different
familiar characteristics, clinical features, and prognosis
have also been identified by EEG methods within a psy-
chiatric population [12]. Reasonably accurate separations
of patients with primary depression from healthy individ-
uals with quantitative EEG (QEEG) multivariable neuro-
metric methods has been repeatedly demonstrated and
replicated in large samples by one research group [13].
We aimed to use prospective and blinded analysis of EEG
and QEEG [14,15] to investigate whether the AUDS group
had more epileptiform and slow (delta and theta) activity
in the frontal, temporal and posterior brain regions than
major depressive patients in the course of an acute admis-
sion. We also aimed to study if regional alpha activity,
posterior alpha frequency and regional QEEG asymmetry
differed between the two groups. By this study we hoped
to clarifiy the pathophysiology and nosological status of
these unstable depressive patients.
Methods
Population
The following criteria had to be fulfilled for inclusion in
the study group (AUDS patients): A history of a rapidly
developing psychiatric condition starting within the last
14 days. Within these 14 days the patient had at different
times shown symptoms that met criteria for at least two
diagnoses in the Diagnostic and Statistical Manual of
Mental Disorders, fourth edition (DSM-IV) Axis 1 catego-
ries (with exception of the time criterion) [16]. One of
these new DSM-IV Axis 1 categories had to be a depressive
episode (with exception of the time criterion) defined as
Montgomery and Aasberg Depression Rating Scale
(MADRS) ≥ 20 [17]. Patients with one of the following
conditions were excluded: a psychiatric condition due to
direct effects of acute intoxication, dementia or mental
disabilities to such a degree that informed consent could
not be obtained, unstable personality disorder with iden-
tical symptoms at former admissions, or unable to speak
English or Norwegian. From a total of 1984 admittances
we evaluated 1038 persons for inclusion. Twenty-eight
fulfilled criteria for inclusion in the study group. Twelve
were not included (not willing to participate, informed
consent not possible to obtain, mentally disabled to an
extensive degree, or not speaking Norwegian or English).
Sixteen patients entered the study group (AUDS). Mean
age was 32.1 years (Table 1). Their co-diagnoses (with
exception of the time criterion) were DSM-IV 298.8 "brief
psychotic disorder" (nine patients), DSM-IV 300.1 "panic
disorder" (four patients) and DSM-IV 296.0 "single manic
episode" (three patients).
The control group consisted of 16 acutely admitted sex-
and age (+/- 5 years), matched patients meeting criteria
(MADRS ≥ 20) for current Axis 1 major depressive episode
(MDE). Mean age was 32.8 years (Table 1). The first
patient meeting such criteria after inclusion of a study
group patient was recruited to the control group. Written
consent was obtained from all the patients prior to inclu-
sion. The study was performed in accordance with the eth-
ical standards laid down in the 1964 Declaration of
Helsinki. The Regional Ethical Committee approved of
the study.
Other Assessments
We examined the patients on day 2, day 4–6, day 14–16
and after 3 months. Alcohol use was assessed with The
Alcohol Use Disorders Identification Test (AUDIT) [18].
Illicit drug use was assessed with the Structural Clinical
Interview for DSM-IV (SCID-1) [19], and urine samples
were screened for drugs at admittance. Current medica-
tion concentrations were analyzed in blood samples at
admittance.
EEG recording and visual analysis
We obtained thirty minutes of eyes-closed EEG-videome-
try on day 2, day 4–5, and day 8–10 after admittance.
Three tests were performed in order to increase the proba-
bility of detecting epileptiform activity as well as to evalu-
ate time-related effects caused by e.g. drug use. They were
all done at the same time of day (+/- 1.5 hours). We used
digital equipment (Nervus 2.4 or 3.0) with 21 EEG elec-
trodes placed according to the 10/20 international system,
electrocardiography (ECG) and eye movement detectionPage 2 of 8
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min of hyperventilation were performed. Data loss
occurred in one AUDS patient in test 2, and in 3 MDE
patients in test 3. An experienced EEG physician blinded
for the diagnosis interpreted and performed a clinical EEG
analysis with classification of alpha frequency, epileptic
spike activity and focal-and generalized slow activity. Eye
opening and closing were performed every minute in
order to control vigilance fluctuations. An experienced
EEG technician noted presence of drowsiness in the
recording. The technician, the physician and others doing
the analyses and statistical work were blinded regarding
the patient group.
QEEG of analysis of baseline activity
We selected artefact free epochs of 4 seconds duration.
Epochs with eyeblinks, muscle artefacts, electrode/move-
ment artefacts, epileptiform activity and drowsiness were
excluded. The total duration of such epochs was between
20 s and 60 s. We used the average reference montage, a
band pass filter of 0.5 Hz – 70 Hz and a 50 Hz notch filter.
Sixteen channels (F3, F4, F7, F8, T3, T4, T5, T6, O1, O2,
C3, C4, P3, P4, T1 and T2) were exported to MATLAB™.
The time/amplitude series had a sampling frequency of
256 Hz. For each selected EEG-segment we eliminated the
start/end-discontinuities by using a cosine window. Fast
Fourier Transform (FFT) was performed on four second
samples (N = 1024 points), with two seconds overlap.
This transform computes the power spectrum (EEG-
power in μV2 on the y-axis as a function of frequency in Hz
in the x-axis). The average amplitude spectra (square root
of power) across all the 4 seconds long samples were
thereafter calculated and smoothed. Band amplitudes
were calculated as the sum of spectral amplitudes for all
bins in the frequency band and used in the statistical com-
parisons. The frequency bands were delta (1–3.75 Hz),
theta (4–7.75 Hz), and alpha (8–12.75 Hz).
For regional analysis we averaged mean frontocentral,
(F3, F4, F7, F8, C3, C4), temporal (T3, T4, T5, T6, T1, T2)
and parietooccipital (O1, O2, P3, P4) amplitudes.
We calculated alpha peak frequencies at the occipital elec-
trodes (O1 and O2). In addition we calculated the crude
hemispheric asymmetry (absolute value of the difference
between right side and left side: ABS (right-left) for all
amplitude and peak frequency measures.
Statistical methods
Categorical group differences were tested with Fisher's
exact test. For the main QEEG analysis we used mean val-
ues (test one + test two + test three/3) and analyzed group
differences with Mann-Whitney U tests for amplitude, fre-
quency and asymmetry. As we used non-parametric tests,
no log transformations were necessary. We performed
subgroup analyses on AUDS patients using anti-epileptic
treatment (compared to those who did not and the MDE
group) with Kruskall-Wallis tests. Possible significant out-
comes were tested with post-hoc Mann-Whitney U tests to
identify the deviating group. In order to estimate possible
drug or abstinence influence on the EEG, we performed
an additional analysis on the third test (Possible absti-
nence or illegal drug effects would minimally influence
the test 10 days after admittance). We studied multiple
Table 1: Clinical background data
AUDS patients MDE patients p-value
n = 16 N = 16
Agea 32.1 (11.4, 19–58) 32.8 (13.0, 18–62) 0.99e
Gender (men) 6 (38%) 6 (38%) 1.00f
Neuroleptic medicationg 13 (81%) 14 (88%) 1.00f
Anti-epileptic medication 11 (62.5%) 1 (6.25%) 0.001f
Alcohol abuseb 4 (27%)c 4 (31%)d 1.00f
Drowsiness 11 (69%) 11 (69%) 1.00f
Number of subjects (%)
a Mean (SD, range)
b The Alcohol Use Disorders Identification Test (AUDIT) ≥ 8
cn = 15 dn = 13
eMann-Whitney test fFisher exact test
g anti-depressive and anti-psychotic medication
AUDS: Acute Unstable Depressive Syndrome. MDE: Major Depressive EpisodePage 3 of 8
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rection for multiple significance testing. These corrections
are not generally appropriate in such studies [20,21]. Two
sided p- values ≤ 0.05 are reported as significant. A two-
sample Student's t-test with 32 subjects has 72% power to
detect an effect = 90% of group SD.
Results
Clinical EEG
Eight (50%) of the AUDS patients and one (6%) of the
MDE patients had two or more abnormal features after
three registrations (p = 0.016, Table 2). More AUDS than
MDE patients had abnormal EEGs: In the first test 38% of
AUDS patients and 25% of MDE patients had abnormal
EEG. Epileptiform sharp activity, focal slow activity, and
generalized slow activity were all found in more AUDS
patients than MDE patients, but differences did not reach
statistical significance.
QEEG
We found significantly higher temporal delta band ampli-
tude in AUDS patients- than in MDE patients (Table 3,
Figure 1). Delta activity was most prominent in the right
hemisphere (Figure 2). Delta asymmetry was larger in
AUDS than MDE in all regions (Table 4, Figure 3). Twelve
of 16 AUDS patients had temporal delta amplitude above
8.9 μV as compared to 3 of 16 MDE patients (sensitivity
76%, specificity 81% for this cut-off). Three MDE – and
11 AUDS patients had absolute temporal delta amplitude
side difference above 0.1 μV (sensitivity 69%, specificity
81% for this cut-off). These cutoffs were selected by trial
and error after inspection of the box-and-whisker plots as
those that yielded the optimal separation between the two
groups.
Although the AUDS patients had slower occipital alpha
peak frequency than the MDE patients, neither this differ-
ence nor the peak frequency asymmetry was significantly
different between groups (Table 3).
Background data
Drowsiness and AUDIT scores did not differ between
groups (Table 1). Comparing band amplitudes in the
third test only (in order to eliminate possible effects of
drug or alcohol abstinence) did confirm our main result:
increased temporal delta amplitude was found in AUDS
patients compared to the MDE patients (10.3 μV vs. 8.5
μV, p = 0.04). More AUDS patients than MDE patients
used anti-epileptic medication (Table 1). Some patients
used more than one medicament: seven patients were on
lamotrigine, one patient used valproate, and three
patients used carbamazepine, while four patients and one
control used clonazepam. However, subgroup analyses
showed that antiepileptic drug use did not influence any
of the significant results in Table 3 and 4. Indeed the
AUDS subgroup not using anti-epileptic drugs did also
have significantly more temporal delta activity than MDE
patients (mean (SD) 9.4 (0.8) μV vs. 8.5 (1.6) μV, p =
0.04).
Discussion
More AUDS than MDE patients had multiple abnormal
features in their EEG. Other studies, suggest that individu-
als with EEG abnormalities within the affective disorder
group may have another symptomatology and aetiology
of the disorder. [12]. These patients may have an organic
basis for the disease [22-25]. Our findings accordingly
suggest that more AUDS than MDE patients may have an
organic origin to their symptoms.
QEEG delta amplitude was significantly higher in AUDS
than MDE patients. QEEG is a more sensitive method
than visual EEG inspection [15]. Delta activity is a rela-
tively unspecific finding. Slow waves between 0.5 and 4
Hz prevail naturally during sleep [26]. Pathological poly-
morphic delta activity can be elicited by lesions of the sub-
cortical white matter, the thalamus and the
mesencephalic reticular formation [27] most likely pro-
duced by the pyramidal neurons of the cortex [28]. In cats,
localized delta activity appears in cortex overlying a cir-
cumscribed white matter lesion, but may also result from
a localized thalamic lesion. Unilateral diffuse delta activ-
ity appears on the side of thalamic or hypothalamic
lesions, whilst bilateral delta activity results from bilateral
lesions of the midbrain tegmentum [29]. Presumably,
diminished cholinergic influence from cortical projecting
neurons of the basal forebrain induces the delta activity
[26]. Localized lesions of the cerebral cortex do not pro-
duce delta activity on the other hand [29]. Generally,
either a structural lesion, a metabolic abnormality, or
lesional epileptiform activity should be considered [30].
Table 2: Visually interpreted (clinical) EEG results
AUDS patients
n = 16
MDE patients
n = 16
p valuea
Focal slow activity 5 (31%) 3 (19%) 0.69
General slow activity 5 (31%) 2 (13%) 0.39
Epileptiform activity 5 (31%) 2 (13%) 0.39
0–1 abnormal feature 8 (50%) 15 (94%) 0.016b
≥ 2 abnormal features 8 (50%) 1 (6%)
Number of subjects (%) with abnormal EEG-features in at least one of 
three testsaFisher's exact test. AUDS: Acute Unstable Depressive 
Syndrome. MDE: Major Depressive Episode
bThe cutoff employed is the median number of abnormal featuresPage 4 of 8
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side was observed in the AUDS group. Hemispheric asym-
metry with right sided dominance found in psychosis has
been attributed to left side deficiency with the right side
becoming dominant because of a lack of interhemispheric
suppression [31]. Epilepsy should also be considered, as
recurrent brief depressive episodes have been described
both in postictal dysphoria and interictal dysphoric disor-
der in epilepsy [32]. A temporal epileptogenic lesion tend
to be associated with polymorphic slow activity or runs of
rhythmic delta or theta activity [33], but neither EEG-pat-
tern was observed. Visual EEG did not provide evidence
for significantly increased epileptiform activity. Lesional
epilepsy is accordingly less likely in AUDS.
Decreased delta activity in MDE patients, as opposed to
increased activity in the AUDS group, could have contrib-
uted to the observed group difference [34]. However, as
more clinical EEG abnormalities were also seen in AUDS
than in MDE patients, it seems likely that the group differ-
ence originates from excess delta activity in AUDS
patients. Healthy controls must also be studied with a
larger cohort of MDE and AUDS patients to settle this
question. In addition it cannot be ruled out that a depres-
sion-related factor in the AUDS group explains or contrib-
utes to the observed EEG asymmetry [35], as elevated right
side delta power has been reported in depressed patients
[36]. However this is less likely, as depression mostly has
been associated with increased alpha and beta power and
asymmetry rather than increased slowing [37,38]. The use
of other EEG-analytical methods seems to indicate a more
diverse broad-band dysfunction in depressives [39].
Asymmetry was not found among unselected depressives
in a recent blinded study [34].
Table 3: Quantitative electroencephalography (QEEG) findings
AUDS patients
n = 16
MDE patients
n = 16
p-valuea
Delta activity (μV)
frontocentral 8.8 (2.3) 7.6 (1.6) 0.08
temporal 10.3 (3.1) 8.5 (1.6) 0.03
parietooccipital 8.8 (2.9) 7.21 (1.4) 0.10
Theta activity (μV)
frontocentral 7.6 (3.4) 6.9 (2.5) 0.78
temporal 9.0 (4.3) 7.8 (2.5) 0.67
parietooccipital 8.5 (4.2) 7.5 (2.8) 0.56
Alpha activity (μV)
frontocentral 10.9 (4.8) 11.7 (4.6) 0.59
temporal 12.4 (5.8) 12.7 (4.8) 0.62
parietooccipital 14.9 (9.3) 15.1 (5.8) 0.42
Alpha peak frequency (Hz)
occipital 9.94 (0.63) 10.24 (0.73) 0.27
occipital absolute side difference 0.86 (0.71) 0.46 (0.38) 0.13
Mean regional spectral amplitudes in μV (Standard deviation, SD) and alpha peak frequency in Hz (SD). Test 1, 2 and 3, (left and right side) values 
have been averaged.
aMann-Whitney U test,
AUDS: Acute Unstable Depressive Syndrome. MDE: Major Depressive EpisodePage 5 of 8
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patients could naturally contributed to the results. Coex-
istent anxiety may be linked with right frontal EEG dys-
function in depression [40]. John et al [31] have found
power asymmetry, with more power in the right side in all
or almost all bands to be a common feature of psychotic
patients independent of whether the psychosis were due
to schizophrenia, depression or alcohol as well as medica-
tion status. Half of the AUDS population was co-diag-
nosed with psychosis; hence this state may have
contributed to the elevated asymmetry numbers.
Although the nosological status of AUDS patients pres-
ently is not clear, our results also suggest that presence of
co-morbidity should be paid even more attention to in
future EEG-studies in depression.
Other explanations for EEG-slowing should also be con-
sidered. First, substance use may affect EEG. Slow EEG
activity after an alcohol-related seizure has been observed
[41,42], but in the present material, alcohol use was sim-
ilar between groups. Moreover, EEG recorded 8–10 days
after admittance, (free from any pre-hospital medication
influence) confirmed our main results. Second, antiepi-
leptic drugs, like phenytoin and carbamazepine are
known to cause EEG slowing [43] or QEEG slowing [44].
We had a possible medication bias in our material caused
by the use of antiepileptic drugs used as psychiatric stabi-
lizing agents in the study group. Treatment was necessary
for ethical reasons. However, the group without antiepi-
leptic medication alone had significantly more delta activ-
ity than the controls even though our subgroup analyses
were not powered to detect such differences. The results
are therefore most likely not produced by the drug admin-
istration.
The limited number of patients renders our results vulner-
able to type II errors. We emphasize that independent
confirmation is needed. It might be argued that pre-hospi-
tal circumstances are hard to control, and it is uncertain if
a high sensitivity and specificity of QEEG can be achieved
in a clinical setting. However, this study aimed at investi-
gating patients "as they are" in a realistic acute psychiatric
setting because the diagnostic challenge arises here, not in
a controlled environment. We have used a well-matched
control group admitted under equal circumstances as
these "real life patients". EEG is nevertheless useful for the
diagnostic process in acute psychiatric settings [10] e.g. for
Table 4: Asymmetry in QEEG parameters
AUDS patients
n = 16
MDE patients
n = 16
p-valuea
Frontocentral region (μV)
delta 0.35 (0.18) 0.25 (0.23) 0.076
theta 0.25 (0.20) 0.33 (0.27) 0.52
alfa 0.41 (0.33) 0.50 (0.51) 0.79
Temporal region (μV)
delta 0.66 (0.53) 0.27 (0.28) 0.009
theta 0.53 (0.37) 0.40 (0.30) 0.12
alfa 1.18 (1.48) 0.85 (0.74) 0.85
Parietooccipital region (μV)
delta 0.60 (0.68) 0.26 (0.29) 0.05
theta 0.60 (0.81) 0.49 (0.61) 0.82
alfa 1.05 (0.95) 0.96 (1.20) 0.35
Absolute difference in μV (SD) between right and left side electrode 
regions.
Test 1, 2 and 3 values have been averaged.
aMann-Whitney U test,
AUDS: Acute Unstable Depressive Syndrome. MDE: Major 
Depressive Episode
Delta amplitude in frontocentral temporal and parietooccipi-tal regionsFigure 1
Delta amplitude in frontocentral temporal and parie-
tooccipital regions. The difference is significant in the tem-
poral region (p = 0.03), and tends to be significant in the 
frontocentral region (p = 0.08, Mann-Whitney U tests) 
(Table 3). Box-and whisker plot shows median, ± 25% per-
centile (box) and range. μV: micro volt, the y axis in the 
amplitude- (square root of power) spectrum.
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encephalopathy. With the development of large, commer-
cially available QEEG databases, some QEEG techniques
may grow towards clinical utility [13].
Conclusion
Our results suggest that a group of patients with rapidly
fluctuating psychiatric symptoms including depression
have more abnormal EEG, compared to patients with
MDE. The findings suggest more pronounced organic
brain dysfunction in AUDS- than in MDE patients.
Although the hypothesized association between epilepsy
and AUDS was not statistically confirmed in the present
study, a subgroup of AUDS patients had epileptiform
activity in their EEG. The nosological status of these
patients is not yet clear and a more detailed study of clin-
ical and neuroradiological features is underway.
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